about
Metabonomic window into hepatitis B virus-related hepatic diseasesReasons why West Africa continues to be a hotbed for hepatocellular carcinomaMetabolic profiling of hepatitis B virus-related hepatocellular carcinoma with diverse differentiation grades.Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.Survival of patients with primary liver cancer in central and northern Denmark, 1998-2009.The promise of metabolic phenotyping in gastroenterology and hepatology.Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.Significance of Serum Cytokeratin-18 in Prediction of Hepatocellular Carcinoma in Chronic Hepatitis C Infected Egyptian Patients.Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinomaHCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre studyComparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.Herb-Drug Interaction between the Traditional Hepatoprotective Formulation and Sorafenib on Hepatotoxicity, Histopathology and Pharmacokinetics in Rats.GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma.Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation.
P2860
Q26771253-8BCB7F61-0384-466B-911D-03D97A3A4BE7Q26772209-6A32471F-B7C0-4358-9CDC-CADE38DC5C42Q33597976-394F3D32-B80D-46D8-B63E-293864987E76Q33684950-C5B77053-FDD4-4FE0-9605-962FC82009E3Q34028475-4155B1F2-FCAC-49A7-90DD-8F3458EADB0AQ35131233-19121DF6-A0C2-45F1-9728-9190B85CBBD0Q35701279-CB88060D-84F3-4D81-B2F0-1323874E0B5BQ36285621-C3E101CF-008B-4AA4-8A74-AC3602CDB792Q36929039-8F86EA31-5454-4FD8-BCB7-05981A9E98A9Q36932065-00BA175C-6954-4C7A-A16F-77AF7E00CC74Q37182242-3662118F-C593-46FE-B7DF-06F8F421EB5DQ37606553-04DDE5C9-2B46-4620-AB97-D9A1E69FD012Q37657319-9EDB7465-9DDA-4630-A41C-668CB9CFB9E1Q38714036-72186429-4BD9-404C-9BA8-F907BED76995Q39630392-00AF3825-7991-4E60-A342-E8D08AC48D53Q40684744-9D3FFF7F-2F15-43BC-B0A8-3D726FCDCB3FQ44088955-FA1D23D8-C19B-46DA-9179-2CB512B2D63FQ52564715-08CAD520-34E4-4990-BFBF-3071604EB289
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Hepatocellular carcinoma: diagnostics and screening.
@en
Hepatocellular carcinoma: diagnostics and screening.
@nl
type
label
Hepatocellular carcinoma: diagnostics and screening.
@en
Hepatocellular carcinoma: diagnostics and screening.
@nl
prefLabel
Hepatocellular carcinoma: diagnostics and screening.
@en
Hepatocellular carcinoma: diagnostics and screening.
@nl
P2093
P2860
P1476
Hepatocellular carcinoma: diagnostics and screening.
@en
P2093
Andrew V Thillainayagam
Howard C Thomas
Madhvi Patel
Mohamed I F Shariff
Nimzing G Ladep
Shahid A Khan
Simon D Taylor-Robinson
P2860
P304
P356
10.1111/J.1365-2753.2010.01599.X
P577
2010-11-30T00:00:00Z